WO2004081535A3 - The establishment of proteome structure profile databases and their uses - Google Patents

The establishment of proteome structure profile databases and their uses Download PDF

Info

Publication number
WO2004081535A3
WO2004081535A3 PCT/US2004/007628 US2004007628W WO2004081535A3 WO 2004081535 A3 WO2004081535 A3 WO 2004081535A3 US 2004007628 W US2004007628 W US 2004007628W WO 2004081535 A3 WO2004081535 A3 WO 2004081535A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteome
establishment
structure profile
profile databases
analyze
Prior art date
Application number
PCT/US2004/007628
Other languages
French (fr)
Other versions
WO2004081535A2 (en
Inventor
Yeou-Guang Tsay
Cheng-Nan Wang
Original Assignee
Bionova Corp
Yeou-Guang Tsay
Cheng-Nan Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionova Corp, Yeou-Guang Tsay, Cheng-Nan Wang filed Critical Bionova Corp
Publication of WO2004081535A2 publication Critical patent/WO2004081535A2/en
Publication of WO2004081535A3 publication Critical patent/WO2004081535A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The present invention provides methods for the determination of the proteome, including primary profile and quaternary profile of a proteome. The present invention also provides methods for determining a proteome status in a biological sample. The methods of the invention may be used to analyze the structure of protein drugs or to analyze the status of gene expression.
PCT/US2004/007628 2003-03-12 2004-03-12 The establishment of proteome structure profile databases and their uses WO2004081535A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45389003P 2003-03-12 2003-03-12
US60/453,890 2003-03-12
US52683203P 2003-12-03 2003-12-03
US60/526,832 2003-12-03

Publications (2)

Publication Number Publication Date
WO2004081535A2 WO2004081535A2 (en) 2004-09-23
WO2004081535A3 true WO2004081535A3 (en) 2005-06-23

Family

ID=32994530

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/007628 WO2004081535A2 (en) 2003-03-12 2004-03-12 The establishment of proteome structure profile databases and their uses

Country Status (2)

Country Link
TW (1) TW200508936A (en)
WO (1) WO2004081535A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006133192A2 (en) 2005-06-03 2006-12-14 Waters Investments Limited Generation and use of a catalog of polypeptide-related information for chemical analyses
US20080171394A1 (en) * 2005-07-11 2008-07-17 Astrazeneca Ab Method For Diagnosing Multiple Sclerosis
US20160266141A1 (en) * 2013-10-03 2016-09-15 Bioanalytix, Inc. Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic
WO2017088769A1 (en) * 2015-11-23 2017-06-01 Sun Jet Biotechnology Inc. Method for verifying the primary structure of protein
KR102560646B1 (en) * 2017-08-01 2023-07-27 암젠 인크 Systems and methods for real-time preparation of polypeptide samples for analysis by mass spectrometry
US11726096B2 (en) * 2018-10-04 2023-08-15 Regeneron Pharmaceuticals, Inc. Fast protein sequencing
CN110999979B (en) * 2019-12-20 2021-06-29 云南农业大学 Moringa seed protease capable of promoting sheep milk coagulation and polypeptide prepared by same and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020045194A1 (en) * 2000-04-10 2002-04-18 Cravatt Benjamin F. Proteomic analysis
US20020087273A1 (en) * 2001-01-04 2002-07-04 Anderson Norman G. Reference database

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020045194A1 (en) * 2000-04-10 2002-04-18 Cravatt Benjamin F. Proteomic analysis
US20020087273A1 (en) * 2001-01-04 2002-07-04 Anderson Norman G. Reference database

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANDERSON N.L. AND ANDERSON N.G.: "The human plasma proteome. History, character, and diagnostic prospects", MOLECULAR AND CULLULAR PROTEOMICS, vol. 1, no. 11, 2002, pages 845 - 867, XP002986053 *

Also Published As

Publication number Publication date
WO2004081535A2 (en) 2004-09-23
TW200508936A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
EP1623227A4 (en) Proteins, sensors, and methods of characterizing analytes using the same
WO2007003344A3 (en) Device for quantitative analysis of a metabolite profile
WO2003000853A3 (en) Protein aggregation assays and uses thereof
FI20041323A0 (en) Analyzer, system, and method for determining the desired user population
WO2005057166A3 (en) Detection of conformationally altered proteins and prions
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
WO2003020931A3 (en) Sirna knockout assay method and constructs
WO2006137932A3 (en) Homogeneous analyte detection
DE60211651D1 (en) PROTEOME ANALYSIS PROCEDURE
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
WO2006034264A3 (en) Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
GB2423266B (en) An analyte assay structure in microfluidic chip for quantitative analysis and method for using the same
WO2004094992A3 (en) Methods for analysis of biological dataset profiles
WO2004081535A3 (en) The establishment of proteome structure profile databases and their uses
WO2006116893A3 (en) Mass spectrometric analysis method
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
WO2005033330A3 (en) Fluorescent probes for use in protein kinase inhibitor binding assay
WO2004113574A3 (en) Methods for disease screening
WO2005119230A3 (en) Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
DE60314302D1 (en) MEASURING CELL
WO2002086505A3 (en) Intracellular analysis
HU0100948D0 (en) Antibody competiton binding assay for qualitative detection of the conformation changes and conformation-dependent quantitative detection of glycoprotein p and other cell surface receptors, pumps and proteins, and use thereof
EP1379629A4 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2003098182A3 (en) Method for quantifying molecules
WO2003031642A3 (en) lovE VARIANT REGULATOR MOLECULES

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase